CR11494A - Nuevos derivados de acido 2-mercaptociclopentanocarboxilico, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen - Google Patents
Nuevos derivados de acido 2-mercaptociclopentanocarboxilico, su procedimiento de preparacion y las composiciones farmaceuticas que los contienenInfo
- Publication number
- CR11494A CR11494A CR11494A CR11494A CR11494A CR 11494 A CR11494 A CR 11494A CR 11494 A CR11494 A CR 11494A CR 11494 A CR11494 A CR 11494A CR 11494 A CR11494 A CR 11494A
- Authority
- CR
- Costa Rica
- Prior art keywords
- mercaptociclopentanocarboxilico
- acid
- pharmaceutical compositions
- compositions containing
- preparation procedure
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/61—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a ring other than a six-membered aromatic ring of the carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C327/00—Thiocarboxylic acids
- C07C327/20—Esters of monothiocarboxylic acids
- C07C327/32—Esters of monothiocarboxylic acids having sulfur atoms of esterified thiocarboxyl groups bound to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
- C07C327/34—Esters of monothiocarboxylic acids having sulfur atoms of esterified thiocarboxyl groups bound to carbon atoms of hydrocarbon radicals substituted by carboxyl groups with amino groups bound to the same hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/04—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/34—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/55—Acids; Esters
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Obesity (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Vascular Medicine (AREA)
- Rheumatology (AREA)
- Hospice & Palliative Care (AREA)
- Emergency Medicine (AREA)
- Urology & Nephrology (AREA)
- Psychiatry (AREA)
- Child & Adolescent Psychology (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Endocrinology (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Hydrogenated Pyridines (AREA)
- Pyridine Compounds (AREA)
Abstract
Compuesto de formula (I) en la que R1 representa un atomo de hidrogeno o un grupo de formula COR4, o bien R1 representa un grupo de formula (A)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0903111A FR2947266B1 (fr) | 2009-06-26 | 2009-06-26 | Nouveaux derives d'acide 2-mercaptocyclopentanecarboxylique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
Publications (1)
Publication Number | Publication Date |
---|---|
CR11494A true CR11494A (es) | 2010-09-13 |
Family
ID=41594318
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CR11494A CR11494A (es) | 2009-06-26 | 2010-06-14 | Nuevos derivados de acido 2-mercaptociclopentanocarboxilico, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen |
Country Status (28)
Country | Link |
---|---|
US (1) | US8309341B2 (es) |
EP (1) | EP2272826A1 (es) |
JP (1) | JP5238757B2 (es) |
KR (1) | KR101187394B1 (es) |
CN (1) | CN101928241A (es) |
AP (1) | AP2010005304A0 (es) |
AR (1) | AR078415A1 (es) |
AU (1) | AU2010202563A1 (es) |
BR (1) | BRPI1001935A2 (es) |
CA (1) | CA2707647A1 (es) |
CL (1) | CL2010000694A1 (es) |
CO (1) | CO6300113A1 (es) |
CR (1) | CR11494A (es) |
CU (1) | CU20100133A7 (es) |
EA (1) | EA017867B1 (es) |
EC (1) | ECSP10010292A (es) |
FR (1) | FR2947266B1 (es) |
GT (1) | GT201000184A (es) |
IL (1) | IL206405A0 (es) |
MA (1) | MA32340B1 (es) |
MX (1) | MX2010007070A (es) |
NI (1) | NI201000111A (es) |
NZ (1) | NZ586444A (es) |
PE (1) | PE20110022A1 (es) |
TW (1) | TWI380813B (es) |
UY (1) | UY32702A (es) |
WO (1) | WO2010149888A1 (es) |
ZA (1) | ZA201004398B (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR3046793B1 (fr) * | 2016-01-14 | 2018-01-05 | Les Laboratoires Servier | Nouveaux derives de phosphinanes et azaphosphinanes, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
CN109467506B (zh) * | 2017-09-07 | 2021-12-07 | 江苏瑞科医药科技有限公司 | 一种取代苯乙酸衍生物的制备方法 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4315031A (en) * | 1977-09-01 | 1982-02-09 | Science Union Et Cie | Thiosubstituted amino acids |
US4385062A (en) * | 1980-01-09 | 1983-05-24 | Gruppo Lepetit S.P.A. | 1-[(-2-Mercaptocycloalkyl)carbonyl]-L-proline derivatives, the process for their manufacture, the intermediates for their synthesis and their use as anti-hypertensive agents |
JPS5750955A (en) * | 1980-09-12 | 1982-03-25 | Hokko Chem Ind Co Ltd | Oxime carbamate derivative and insecticide |
JPH0565258A (ja) * | 1991-07-03 | 1993-03-19 | Nippon Bayeragrochem Kk | 酢酸アニリド誘導体および除草剤 |
DE69329199D1 (de) * | 1992-05-29 | 2000-09-14 | Procter & Gamble Pharma | Schwefel-enthaltende phosphonat-verbindungen zur behandlung von abnormalem calzium- und phosphat- metabolismus |
AU2001276605A1 (en) * | 2000-08-17 | 2002-02-25 | Pfizer Inc. | Substituted imidazoles as tafia inhibitors |
EP1497300A2 (en) * | 2002-03-21 | 2005-01-19 | Schering Aktiengesellschaft | Plasma carboxypeptidase b inhibitors |
ES2374973T3 (es) * | 2002-10-04 | 2012-02-23 | Dsm Ip Assets B.V. | Sustrato para la determinación de tafi(a). |
DE102004020186A1 (de) * | 2004-04-22 | 2005-11-17 | Aventis Pharma Deutschland Gmbh | Heterocyclylessigsäuren als Inhibitoren von TAFla |
-
2009
- 2009-06-26 FR FR0903111A patent/FR2947266B1/fr not_active Expired - Fee Related
-
2010
- 2010-06-09 PE PE2010000346A patent/PE20110022A1/es not_active Application Discontinuation
- 2010-06-10 UY UY0001032702A patent/UY32702A/es not_active Application Discontinuation
- 2010-06-14 CR CR11494A patent/CR11494A/es not_active Application Discontinuation
- 2010-06-16 IL IL206405A patent/IL206405A0/en unknown
- 2010-06-18 MA MA32937A patent/MA32340B1/fr unknown
- 2010-06-18 GT GT201000184A patent/GT201000184A/es unknown
- 2010-06-18 AU AU2010202563A patent/AU2010202563A1/en not_active Abandoned
- 2010-06-21 EC EC2010010292A patent/ECSP10010292A/es unknown
- 2010-06-22 ZA ZA2010/04398A patent/ZA201004398B/en unknown
- 2010-06-22 AP AP2010005304A patent/AP2010005304A0/en unknown
- 2010-06-22 CN CN2010102114920A patent/CN101928241A/zh active Pending
- 2010-06-23 NI NI201000111A patent/NI201000111A/es unknown
- 2010-06-24 EA EA201000867A patent/EA017867B1/ru not_active IP Right Cessation
- 2010-06-24 MX MX2010007070A patent/MX2010007070A/es unknown
- 2010-06-24 BR BRPI1001935-9A patent/BRPI1001935A2/pt not_active Application Discontinuation
- 2010-06-24 AR ARP100102230A patent/AR078415A1/es not_active Application Discontinuation
- 2010-06-24 KR KR1020100060062A patent/KR101187394B1/ko not_active IP Right Cessation
- 2010-06-25 US US12/803,405 patent/US8309341B2/en not_active Expired - Fee Related
- 2010-06-25 JP JP2010144460A patent/JP5238757B2/ja not_active Expired - Fee Related
- 2010-06-25 WO PCT/FR2010/000474 patent/WO2010149888A1/fr active Application Filing
- 2010-06-25 TW TW099120891A patent/TWI380813B/zh not_active IP Right Cessation
- 2010-06-25 CA CA2707647A patent/CA2707647A1/fr not_active Abandoned
- 2010-06-25 CU CU20100133A patent/CU20100133A7/es unknown
- 2010-06-25 NZ NZ586444A patent/NZ586444A/en not_active IP Right Cessation
- 2010-06-25 CL CL2010000694A patent/CL2010000694A1/es unknown
- 2010-06-25 CO CO10077072A patent/CO6300113A1/es active IP Right Grant
- 2010-06-25 EP EP10290344A patent/EP2272826A1/fr not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
CA2707647A1 (fr) | 2010-12-26 |
TWI380813B (zh) | 2013-01-01 |
MX2010007070A (es) | 2011-01-05 |
NZ586444A (en) | 2011-09-30 |
TW201105322A (en) | 2011-02-16 |
CL2010000694A1 (es) | 2011-05-06 |
IL206405A0 (en) | 2010-12-30 |
KR20110000516A (ko) | 2011-01-03 |
AP2010005304A0 (en) | 2010-06-30 |
WO2010149888A1 (fr) | 2010-12-29 |
UY32702A (es) | 2010-12-31 |
ZA201004398B (en) | 2011-03-30 |
ECSP10010292A (es) | 2011-06-30 |
CO6300113A1 (es) | 2011-07-21 |
AR078415A1 (es) | 2011-11-09 |
EA017867B1 (ru) | 2013-03-29 |
CN101928241A (zh) | 2010-12-29 |
KR101187394B1 (ko) | 2012-10-02 |
JP5238757B2 (ja) | 2013-07-17 |
FR2947266B1 (fr) | 2011-06-17 |
JP2011006416A (ja) | 2011-01-13 |
GT201000184A (es) | 2012-04-30 |
BRPI1001935A2 (pt) | 2012-03-06 |
AU2010202563A1 (en) | 2011-01-20 |
NI201000111A (es) | 2010-12-17 |
PE20110022A1 (es) | 2011-02-04 |
US20100330064A1 (en) | 2010-12-30 |
US8309341B2 (en) | 2012-11-13 |
CU20100133A7 (es) | 2012-02-15 |
FR2947266A1 (fr) | 2010-12-31 |
EP2272826A1 (fr) | 2011-01-12 |
EA201000867A1 (ru) | 2010-12-30 |
MA32340B1 (fr) | 2011-06-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ECSP12011910A (es) | Derivados de imidazopiridina como inhibidores de jak | |
ECSP11011340A (es) | Nuevos derivados de benzotiadiazepinas, su procedimiento de preparación y composiciones farmacéuticas que los contienen | |
ECSP12012174A (es) | Derivados de n-(imidazopirimidin-7-il)-heteroarilamida y su uso como inhibidores de pde10a | |
ECSP099216A (es) | Nuevos derivados de diosmetina, su procedimiento de preparación y las composiciones farmacéuticas que los contienen | |
ECSP11011439A (es) | Compuestos 1-cianoetilheterociclilcarboxamida sustituidos 750 | |
CR11251A (es) | Depsipeptidos ciclicos y usos de los mismos | |
CO6741154A2 (es) | Compuestos de triazolopiridina | |
UY32704A (es) | Compuestos de 2,3-dihidro-1h-indeno | |
MA33948B1 (fr) | Dérivés d'acide 3-hétéroaroylamino-propionique substitues par oxygène et leur utilisation en tant qu'agents pharmaceutiques. | |
NI201000134A (es) | Nuevos derivados dihidroindolonas, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. | |
MX340147B (es) | Composiciones farmacéuticas y nutracéuticas del ácido abscísico. | |
CR9391A (es) | Derivados de indanil-piperazinas, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen | |
CR11494A (es) | Nuevos derivados de acido 2-mercaptociclopentanocarboxilico, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen | |
UY33574A (es) | Nuevos derivados dihidrobenzoxatiazepinas, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen | |
CR20120109A (es) | Nuevos derivados dihidro-oxazolobenzodiazepinonas, su procedimiento de preparación y las composiciones farmacéuticas que los contienen | |
SV2010003626A (es) | Nuevos compuestos piperidinicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen | |
UY32154A (es) | Derivados de isoquinolinona, procesos para su preparacion, composiciones farmaceuticas que los contiene y su uso en terapia | |
UY33072A (es) | Nuevos derivados de azabiciclo[3.1.0.]hex-2-ilo, su procedimiento de preparación y las composiciones farmacéuticas que los contienen | |
UY30343A1 (es) | Derivados de 1,2,3,4-tetrahidro-quinolina como inhibidores de cetp | |
CR11599A (es) | Nuevos derivados dihidroindolonas, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen | |
CR11811A (es) | Nuevos derivados de azabiciclo[3.2.0]hept-3-ilo, su procedimiento de preparación y las composiciones farmacéuticas que los contienen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal (granting procedure) |